Reverse Abasic Succinate
Reverse Abasic Succinate - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.ON-191
-
SMILESO=C(CCC(O)=O)OC[C@H]1OCC[C@H]1OC(C2=CC=C(OC)C=C2)(C3=CC=CC=C3)C4=CC=C(OC)C=C4
-
Molecular FormulaC30H32O8
-
Molecular Weight520.58
-
AppearanceWhite to yellow powder
-
PurityHPLC≥98.0%
-
Storage Condition-20℃, in tightly closed containers, protected from humidity.
-
RemarksAbasic
Documentation
Documentation
-
Catalog No.ON-191
-
SMILESO=C(CCC(O)=O)OC[C@H]1OCC[C@H]1OC(C2=CC=C(OC)C=C2)(C3=CC=CC=C3)C4=CC=C(OC)C=C4
-
Molecular FormulaC30H32O8
-
Molecular Weight520.58
-
AppearanceWhite to yellow powder
-
PurityHPLC≥98.0%
-
Storage Condition-20℃, in tightly closed containers, protected from humidity.
-
RemarksAbasic
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
